Skadden is representing Mylan Inc. in its $1.6 billion acquisition of Agila Specialties Private Limited (India), a developer, manufacturer and marketer of generic injectable products, from Strides Arcolab Limited (India), announced on February 27.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates